Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
May 20, 2023
Background Reducing the risk of recurrent Plasmodium vivax malaria is critical for malaria control and elimination. Primaquine (PQ) is the…
Analytical approaches for antimalarial antibody responses to confirm historical and recent malaria transmission: an example from the Philippines
May 19, 2023
Background Assessing the status of malaria transmission in endemic areas becomes increasingly challenging as countries approach elimination. Serology can provide…
A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
April 27, 2023
Plasmodium vivax malaria continues to cause a significant burden of disease in the Asia-Pacific, the Horn of Africa, and the Americas….
Reactive surveillance and response strategies for malaria elimination in Myanmar: a literature review
April 27, 2023
Myanmar, a country in Greater Mekong Sub-region, aims to eliminate malaria by 2030. To achieve malaria elimination, Myanmar adopted a…
An archetypes approach to malaria intervention impact mapping: a new framework and example application
April 26, 2023
Background As both mechanistic and geospatial malaria modeling methods become more integrated into malaria policy decisions, there is increasing demand…
Imported malaria and its implication to achievement of malaria-free Bhutan
April 4, 2023
As Bhutan nears malaria elimination, imported malaria through cross-border human mobility has emerged as major source of transmission. This report…
Study protocol for development of an options assessment toolkit (OAT) for national malaria programs in Asia Pacific to determine best combinations of vivax radical cure for their given contexts
March 9, 2023
Recent advances in G6PD deficiency screening and treatment are rapidly changing the landscape of radical cure of vivax malaria available…
Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: A randomized, open-label, non-inferiority trial of early versus delayed treatment
March 9, 2023
Objectives: We aimed to assess safety, tolerability, and Plasmodium vivax relapse rates of ultra-short course (3.5 days) high-dose (1 mg/kg twice…
The spatial signature of Plasmodium vivax and Plasmodium falciparum infections: quantifying the clustering of infections in cross-sectional surveys and cohort studies
March 4, 2023
Background: Over the last decades, enormous successes have been achieved in reducing malaria burden globally. In Latin America, South East Asia,…
Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study
March 1, 2023
Vivax malaria can relapse after an initial infection due to dormant liver stages of the parasite. Radical cure can prevent…